Martin Lukačišin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Martin Lukačišin has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Shai S. Shen-Orr
Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
4 shared publications - Tobias Bollenbach
Institute for Biological Physics, University of Cologne, 50931 Cologne, Germany
4 shared publications - Adriana Espinosa-Cantú
University of Cologne
2 shared publications Ayelet Alpert
Department of Immunology, Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
2 shared publicationsBenjamin LeRoy
Department of Statistics, Carnegie Mellon University, Pittsburgh, USA
2 shared publicationsElina Starosvetsky
Department of Immunology, Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
2 shared publications
Latest Publications
- Open Access
Immune Aging is an Independent Risk Factor for Cardiovascular Disease
Cardiovascular disease remains the leading cause of mortality worldwide, yet substantial risk persists beyond traditional clinical and metabolic predictors. The immune system is a key mediator of this residual risk, but clinically scalable metrics of immune state are lacking. Here, we established the clinical and prognostic relevance of IMM-AGE, a system-level metric of immune aging derived from immune cell correlation structure. We developeda transcriptomic gene-ratio signature and optimized reduced-marker flow cytometry panels that accurately preserve IMM-AGE across blood fractions, platforms and cohorts. Applying these clinic-ready implementations across population-based and disease-specific datasets, we show that elevated IMM-AGE is consistently associated with cardiovascular phenotypes and disease. We leverage the UK biobank to show that incorporation of IMM-AGE into the PREVENT 10-year risk equation increase accuracy of risk stratification. We also show that in elderly patients undergoing transcatheter aortic valve replacement, baseline IMM-AGE independently predicted early maladaptive cardiac remodeling and one-year mortality. Finally, in the Baseline Health Study, a large longitudinal cohort, IMM-AGE stratified cardiovascular event risk among individuals with otherwise similar clinical profiles. Together, these findings establish immune aging as a transferable, biologically grounded risk dimension and support IMM-AGE as a practical tool for precision cardiovascular risk assessment.
Open AccessImmune Aging is an Independent Risk Factor for Cardiovascular Disease
Cardiovascular disease remains the leading cause of mortality worldwide, yet substantial risk persists beyond traditional clinical and metabolic predictors. The immune system is a key mediator of this residual risk, but clinically scalable metrics of immune state are lacking. Here, we established the clinical and prognostic relevance of IMM-AGE, a system-level metric of immune aging derived from immune cell correlation structure. We developeda transcriptomic gene-ratio signature and optimized reduced-marker flow cytometry panels that accurately preserve IMM-AGE across blood fractions, platforms and cohorts. Applying these clinic-ready implementations across population-based and disease-specific datasets, we show that elevated IMM-AGE is consistently associated with cardiovascular phenotypes and disease. We leverage the UK biobank to show that incorporation of IMM-AGE into the PREVENT 10-year risk equation increase accuracy of risk stratification. We also show that in elderly patients undergoing transcatheter aortic valve replacement, baseline IMM-AGE independently predicted early maladaptive cardiac remodeling and one-year mortality. Finally, in the Baseline Health Study, a large longitudinal cohort, IMM-AGE stratified cardiovascular event risk among individuals with otherwise similar clinical profiles. Together, these findings establish immune aging as a transferable, biologically grounded risk dimension and support IMM-AGE as a practical tool for precision cardiovascular risk assessment.
- Open Access
Bacterial exposure drives immune ageing
The immune system is uniquely capable of both regenerating and ageing the rest of the organism based on its own state 1 . Understanding the driving forces behind alterations in the immune system with age has thus potential to lead to interventions against ageing in general 2 . However, the factors driving immune ageing remain largely unknown 3 . Here we show that alterations in response to bacterial exposure are a key driving force of immune ageing. Studying a longitudinal cohort with their immune system characterised in high-dimension 4 , we devised a phenotype-driven gene co-regulation analysis through which we unravel the immune-ageing role for multiple cellular functions, including genes regulated by miRNAs previously reported to cause gut leakiness 5 . Hypothesizing increased bacterial exposure as a driver of immune ageing, we quantified the exposure of each individual’s immune system to bacteria through analysing the residual bacterial DNA content in their immune cells 6 . We found that the total bacterial load is unrelated to the subject’s chronological or immune age, but predicts the change in immune age over the next year. Finally, we rationalise previously observed alterations in cellular composition of the immune system associated with ageing 4 by finding that the immune cell subtypes most increasing in their frequency are highly enriched in expressing bacterial response genes. Our results thus earmark bacterial exposure as the candidate driver to be counteracted in anti-ageing interventions and the immune cell residual bacterial DNA content as a biomarker for the immune systems most at risk of ageing. Overall, these results offer a new paradigm for investigating gut health in the context of ageing 7,8 .
Open AccessBacterial exposure drives immune ageing
The immune system is uniquely capable of both regenerating and ageing the rest of the organism based on its own state 1 . Understanding the driving forces behind alterations in the immune system with age has thus potential to lead to interventions against ageing in general 2 . However, the factors driving immune ageing remain largely unknown 3 . Here we show that alterations in response to bacterial exposure are a key driving force of immune ageing. Studying a longitudinal cohort with their immune system characterised in high-dimension 4 , we devised a phenotype-driven gene co-regulation analysis through which we unravel the immune-ageing role for multiple cellular functions, including genes regulated by miRNAs previously reported to cause gut leakiness 5 . Hypothesizing increased bacterial exposure as a driver of immune ageing, we quantified the exposure of each individual’s immune system to bacteria through analysing the residual bacterial DNA content in their immune cells 6 . We found that the total bacterial load is unrelated to the subject’s chronological or immune age, but predicts the change in immune age over the next year. Finally, we rationalise previously observed alterations in cellular composition of the immune system associated with ageing 4 by finding that the immune cell subtypes most increasing in their frequency are highly enriched in expressing bacterial response genes. Our results thus earmark bacterial exposure as the candidate driver to be counteracted in anti-ageing interventions and the immune cell residual bacterial DNA content as a biomarker for the immune systems most at risk of ageing. Overall, these results offer a new paradigm for investigating gut health in the context of ageing 7,8 .
- Open Access
- 12 June 2024
- Published by Springer Nature in Nature
- Vol. 632 (8024) , 350-356
Interactions between immune cell types facilitate the evolution of immune traits
An essential prerequisite for evolution by natural selection is variation among individuals in traits that affect fitness1. The ability of a system to produce selectable variation, known as evolvability2, thus markedly affects the rate of evolution. Although the immune system is among the fastest-evolving components in mammals3, the sources of variation in immune traits remain largely unknown4,5. Here we show that an important determinant of the immune system’s evolvability is its organization into interacting modules represented by different immune cell types. By profiling immune cell variation in bone marrow of 54 genetically diverse mouse strains from the Collaborative Cross6, we found that variation in immune cell frequencies is polygenic and that many associated genes are involved in homeostatic balance through cell-intrinsic functions of proliferation, migration and cell death. However, we also found genes associated with the frequency of a particular cell type that are expressed in a different cell type, exerting their effect in what we term cyto-trans. The vertebrate evolutionary record shows that genes associated in cyto-trans have faced weaker negative selection, thus increasing the robustness and hence evolvability2,7,8 of the immune system. This phenomenon is similarly observable in human blood. Our findings suggest that interactions between different components of the immune system provide a phenotypic space in which mutations can produce variation with little detriment, underscoring the role of modularity in the evolution of complex systems9.
- 12 June 2024
- Published by Springer Nature in Nature
- Vol. 632 (8024) , 350-356
Open AccessInteractions between immune cell types facilitate the evolution of immune traits
An essential prerequisite for evolution by natural selection is variation among individuals in traits that affect fitness1. The ability of a system to produce selectable variation, known as evolvability2, thus markedly affects the rate of evolution. Although the immune system is among the fastest-evolving components in mammals3, the sources of variation in immune traits remain largely unknown4,5. Here we show that an important determinant of the immune system’s evolvability is its organization into interacting modules represented by different immune cell types. By profiling immune cell variation in bone marrow of 54 genetically diverse mouse strains from the Collaborative Cross6, we found that variation in immune cell frequencies is polygenic and that many associated genes are involved in homeostatic balance through cell-intrinsic functions of proliferation, migration and cell death. However, we also found genes associated with the frequency of a particular cell type that are expressed in a different cell type, exerting their effect in what we term cyto-trans. The vertebrate evolutionary record shows that genes associated in cyto-trans have faced weaker negative selection, thus increasing the robustness and hence evolvability2,7,8 of the immune system. This phenomenon is similarly observable in human blood. Our findings suggest that interactions between different components of the immune system provide a phenotypic space in which mutations can produce variation with little detriment, underscoring the role of modularity in the evolution of complex systems9.
- Open Access
- 18 October 2023
- Published by Springer Nature in Research Square
Interactions between immune cell types facilitate the evolution of immune traits
An essential prerequisite for evolution by natural selection is variation among individuals in traits that affect fitness1. The ability of a system to produce selectable variation, known as evolvability2, thus greatly affects the rate of its evolution. The immune system belongs to the fastest evolving components of mammalian genomes3, yet the sources of useful variation in immune traits remain largely unknown4,5. Here, we show that a key determinant of the immune system’s evolvability is its organisation into interacting modules represented by different immune cell types. By profiling immune cell variation in bone marrow of 54 genetically diverse mouse strains from the Collaborative Cross6, we found that variation in immune cell frequencies is polygenic and that associated genes are largely involved in quantitative homeostasis through cell-intrinsic functions of proliferation, migration and cell death. However, we also found that many genes influencing the frequency of a particular cell type are not expressed in that specific cell type, but rather in a different immune cell type. Vertebrate evolutionary record shows that genes implicated in this non-cell-intrinsic variation have faced fewer purifying constraints, indicating that they have acted as key determinants in the recent evolvability of immune traits. Our findings suggest that interactions between different components of the immune system provide a phenotypic space where mutations can produce selectable variation without much detriment, offering a solution to the robustness-evolvability conundrum2,7,8 in the context of the immune system.
- 18 October 2023
- Published by Springer Nature in Research Square
Open AccessInteractions between immune cell types facilitate the evolution of immune traits
An essential prerequisite for evolution by natural selection is variation among individuals in traits that affect fitness1. The ability of a system to produce selectable variation, known as evolvability2, thus greatly affects the rate of its evolution. The immune system belongs to the fastest evolving components of mammalian genomes3, yet the sources of useful variation in immune traits remain largely unknown4,5. Here, we show that a key determinant of the immune system’s evolvability is its organisation into interacting modules represented by different immune cell types. By profiling immune cell variation in bone marrow of 54 genetically diverse mouse strains from the Collaborative Cross6, we found that variation in immune cell frequencies is polygenic and that associated genes are largely involved in quantitative homeostasis through cell-intrinsic functions of proliferation, migration and cell death. However, we also found that many genes influencing the frequency of a particular cell type are not expressed in that specific cell type, but rather in a different immune cell type. Vertebrate evolutionary record shows that genes implicated in this non-cell-intrinsic variation have faced fewer purifying constraints, indicating that they have acted as key determinants in the recent evolvability of immune traits. Our findings suggest that interactions between different components of the immune system provide a phenotypic space where mutations can produce selectable variation without much detriment, offering a solution to the robustness-evolvability conundrum2,7,8 in the context of the immune system.
- Open Access
- 31 July 2022
- Published by Wiley in Clinical and Translational Medicine
- Vol. 12 (8) , e1005
Single‐cell isogrowth profiling: Uniform inhibition uncovers non‐uniform drug responses
- 31 July 2022
- Published by Wiley in Clinical and Translational Medicine
- Vol. 12 (8) , e1005
Open AccessSingle‐cell isogrowth profiling: Uniform inhibition uncovers non‐uniform drug responses
- Open Access
- 20 April 2022
- Published by Springer Nature in Nature
- Vol. 605 (7908) , 113-118
Intron-mediated induction of phenotypic heterogeneity
Intragenic regions that are removed during maturation of the RNA transcript—introns—are universally present in the nuclear genomes of eukaryotes1. The budding yeast, an otherwise intron-poor species, preserves two sets of ribosomal protein genes that differ primarily in their introns2,3. Although studies have shed light on the role of ribosomal protein introns under stress and starvation4–6, understanding the contribution of introns to ribosome regulation remains challenging. Here, by combining isogrowth profiling7with single-cell protein measurements8, we show that introns can mediate inducible phenotypic heterogeneity that confers a clear fitness advantage. Osmotic stress leads to bimodal expression of the small ribosomal subunit protein Rps22B, which is mediated by an intron in the 5′ untranslated region of its transcript. The two resulting yeast subpopulations differ in their ability to cope with starvation. Low levels of Rps22B protein result in prolonged survival under sustained starvation, whereas high levels of Rps22B enable cells to grow faster after transient starvation. Furthermore, yeasts growing at high concentrations of sugar, similar to those in ripe grapes, exhibit bimodal expression of Rps22B when approaching the stationary phase. Differential intron-mediated regulation of ribosomal protein genes thus provides a way to diversify the population when starvation threatens in natural environments. Our findings reveal a role for introns in inducing phenotypic heterogeneity in changing environments, and suggest that duplicated ribosomal protein genes in yeast contribute to resolving the evolutionary conflict between precise expression control and environmental responsiveness9.
- 20 April 2022
- Published by Springer Nature in Nature
- Vol. 605 (7908) , 113-118
Open AccessIntron-mediated induction of phenotypic heterogeneity
Intragenic regions that are removed during maturation of the RNA transcript—introns—are universally present in the nuclear genomes of eukaryotes1. The budding yeast, an otherwise intron-poor species, preserves two sets of ribosomal protein genes that differ primarily in their introns2,3. Although studies have shed light on the role of ribosomal protein introns under stress and starvation4–6, understanding the contribution of introns to ribosome regulation remains challenging. Here, by combining isogrowth profiling7with single-cell protein measurements8, we show that introns can mediate inducible phenotypic heterogeneity that confers a clear fitness advantage. Osmotic stress leads to bimodal expression of the small ribosomal subunit protein Rps22B, which is mediated by an intron in the 5′ untranslated region of its transcript. The two resulting yeast subpopulations differ in their ability to cope with starvation. Low levels of Rps22B protein result in prolonged survival under sustained starvation, whereas high levels of Rps22B enable cells to grow faster after transient starvation. Furthermore, yeasts growing at high concentrations of sugar, similar to those in ripe grapes, exhibit bimodal expression of Rps22B when approaching the stationary phase. Differential intron-mediated regulation of ribosomal protein genes thus provides a way to diversify the population when starvation threatens in natural environments. Our findings reveal a role for introns in inducing phenotypic heterogeneity in changing environments, and suggest that duplicated ribosomal protein genes in yeast contribute to resolving the evolutionary conflict between precise expression control and environmental responsiveness9.
- Open Access
Intron-mediated induction of phenotypic heterogeneity
Introns are universally present in the nuclear genomes of eukaryotes 1 . The budding yeast, an otherwise intron-poor species, preserves two sets of ribosomal protein (RP) genes differing primarily in their introns 2–4 . Despite recent findings on the role of RP introns under stress and starvation 5–7 , understanding the contribution of introns to ribosome regulation remains challenging. Here, combining isogrowth profiling 8 with single-cell protein measurements 9 , we found that introns can mediate inducible phenotypic heterogeneity conferring a clear fitness advantage. Osmotic stress leads to bimodal expression of the small ribosomal subunit protein Rps22B, mediated by an intron in the 5’ untranslated region of its transcript. The two resulting yeast subpopulations differ in their ability to cope with starvation. Low Rps22B protein levels resulted in prolonged survival under sustained starvation, while high Rps22B levels enabled cells to grow faster after transient starvation. Further, yeast growing at high sugar concentrations – similar to those in ripe grapes – exhibit bimodal Rps22B expression when approaching stationary phase. Differential intron-mediated regulation of RP genes thus provides a way to diversify the population when starvation looms in natural environments. Our findings reveal a new role for introns in inducing phenotypic heterogeneity in changing environments and suggest that duplicated RP genes in yeast contribute to resolving the evolutionary conflict between precise expression control and environmental responsiveness 10 .
Open AccessIntron-mediated induction of phenotypic heterogeneity
Introns are universally present in the nuclear genomes of eukaryotes 1 . The budding yeast, an otherwise intron-poor species, preserves two sets of ribosomal protein (RP) genes differing primarily in their introns 2–4 . Despite recent findings on the role of RP introns under stress and starvation 5–7 , understanding the contribution of introns to ribosome regulation remains challenging. Here, combining isogrowth profiling 8 with single-cell protein measurements 9 , we found that introns can mediate inducible phenotypic heterogeneity conferring a clear fitness advantage. Osmotic stress leads to bimodal expression of the small ribosomal subunit protein Rps22B, mediated by an intron in the 5’ untranslated region of its transcript. The two resulting yeast subpopulations differ in their ability to cope with starvation. Low Rps22B protein levels resulted in prolonged survival under sustained starvation, while high Rps22B levels enabled cells to grow faster after transient starvation. Further, yeast growing at high sugar concentrations – similar to those in ripe grapes – exhibit bimodal Rps22B expression when approaching stationary phase. Differential intron-mediated regulation of RP genes thus provides a way to diversify the population when starvation looms in natural environments. Our findings reveal a new role for introns in inducing phenotypic heterogeneity in changing environments and suggest that duplicated RP genes in yeast contribute to resolving the evolutionary conflict between precise expression control and environmental responsiveness 10 .
- Open Access
- 1 November 2019
- Published by Elsevier in Cell Systems
- Vol. 9 (5) , 423-433.e3
Emergent Gene Expression Responses to Drug Combinations Predict Higher-Order Drug Interactions
- 1 November 2019
- Published by Elsevier in Cell Systems
- Vol. 9 (5) , 423-433.e3
Open AccessEmergent Gene Expression Responses to Drug Combinations Predict Higher-Order Drug Interactions
- Open Access
- 16 March 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (3) , e0174066
Sequence-specific thermodynamic properties of nucleic acids influence both transcriptional pausing and backtracking in yeast
RNA Polymerase II pauses and backtracks during transcription, with many consequences for gene expression and cellular physiology. Here, we show that the energy required to melt double-stranded nucleic acids in the transcription bubble predicts pausing in Saccharomyces cerevisiae far more accurately than nucleosome roadblocks do. In addition, the same energy difference also determines when the RNA polymerase backtracks instead of continuing to move forward. This data-driven model corroborates—in a genome wide and quantitative manner—previous evidence that sequence-dependent thermodynamic features of nucleic acids influence both transcriptional pausing and backtracking.
- 16 March 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (3) , e0174066
Open AccessSequence-specific thermodynamic properties of nucleic acids influence both transcriptional pausing and backtracking in yeast
RNA Polymerase II pauses and backtracks during transcription, with many consequences for gene expression and cellular physiology. Here, we show that the energy required to melt double-stranded nucleic acids in the transcription bubble predicts pausing in Saccharomyces cerevisiae far more accurately than nucleosome roadblocks do. In addition, the same energy difference also determines when the RNA polymerase backtracks instead of continuing to move forward. This data-driven model corroborates—in a genome wide and quantitative manner—previous evidence that sequence-dependent thermodynamic features of nucleic acids influence both transcriptional pausing and backtracking.
- Top Cited PapersOpen Access
- 21 October 2012
- Published by Springer Nature in Nature Cell Biology
- Vol. 14 (11) , 1212-1222
Elf5 inhibits the epithelial–mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2
The epithelial–mesenchymal transition (EMT) is a complex process that occurs during organogenesis and in cancer metastasis. Despite recent progress, the molecular pathways connecting the physiological and pathological functions of EMT need to be better defined. Here we show that the transcription factor Elf5, a key regulator of mammary gland alveologenesis, controls EMT in both mammary gland development and metastasis. We uncovered this role for Elf5 through analyses of Elf5 conditional knockout animals, various in vitro and in vivo models of EMT and metastasis, an MMTV-neu transgenic model of mammary tumour progression and clinical breast cancer samples. Furthermore, we demonstrate that Elf5 suppresses EMT by directly repressing the transcription of Snail2, a master regulator of mammary stem cells and a known inducer of EMT. These findings establish Elf5 not only as a key cell lineage regulator during normal mammary gland development, but also as a suppressor of EMT and metastasis in breast cancer.
- 21 October 2012
- Published by Springer Nature in Nature Cell Biology
- Vol. 14 (11) , 1212-1222
Top Cited PapersOpen AccessElf5 inhibits the epithelial–mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2
The epithelial–mesenchymal transition (EMT) is a complex process that occurs during organogenesis and in cancer metastasis. Despite recent progress, the molecular pathways connecting the physiological and pathological functions of EMT need to be better defined. Here we show that the transcription factor Elf5, a key regulator of mammary gland alveologenesis, controls EMT in both mammary gland development and metastasis. We uncovered this role for Elf5 through analyses of Elf5 conditional knockout animals, various in vitro and in vivo models of EMT and metastasis, an MMTV-neu transgenic model of mammary tumour progression and clinical breast cancer samples. Furthermore, we demonstrate that Elf5 suppresses EMT by directly repressing the transcription of Snail2, a master regulator of mammary stem cells and a known inducer of EMT. These findings establish Elf5 not only as a key cell lineage regulator during normal mammary gland development, but also as a suppressor of EMT and metastasis in breast cancer.